<code id='48C2390E96'></code><style id='48C2390E96'></style>
    • <acronym id='48C2390E96'></acronym>
      <center id='48C2390E96'><center id='48C2390E96'><tfoot id='48C2390E96'></tfoot></center><abbr id='48C2390E96'><dir id='48C2390E96'><tfoot id='48C2390E96'></tfoot><noframes id='48C2390E96'>

    • <optgroup id='48C2390E96'><strike id='48C2390E96'><sup id='48C2390E96'></sup></strike><code id='48C2390E96'></code></optgroup>
        1. <b id='48C2390E96'><label id='48C2390E96'><select id='48C2390E96'><dt id='48C2390E96'><span id='48C2390E96'></span></dt></select></label></b><u id='48C2390E96'></u>
          <i id='48C2390E96'><strike id='48C2390E96'><tt id='48C2390E96'><pre id='48C2390E96'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:73249

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

          advertisement

          Sponsor Introduction

          • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

          Featured Speakers

          • Angus Chen, cancer reporter, STAT
          • Adam Feuerstein, senior writer, biotech, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Katherine MacPhail, programmer, editorial events, STAT (moderator)

          Sponsored By

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Why Novartis is going to walk from its acquisition of MorphoSys
          Why Novartis is going to walk from its acquisition of MorphoSys

          MollyFerguson/STATNovartissaidMondaythatitintendstobuyMorphoSysforjustunder$3billion.Thedealwillnotc

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Medicare to cover more brain scans related to Alzheimer’s drugs

          Illustration:AlexHogan/STAT;Photo:EisaiviaAPMedicarehasofficiallyexpandeditscoveragepolicyforbrainsc